Last reviewed · How we verify

placebo and tramadol — Competitive Intelligence Brief

placebo and tramadol (placebo and tramadol) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Opioid analgesic with monoamine reuptake inhibition. Area: Pain Management.

marketed Opioid analgesic with monoamine reuptake inhibition Mu-opioid receptor; norepinephrine transporter; serotonin transporter Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

placebo and tramadol (placebo and tramadol) — University of Southern Denmark. Tramadol is a synthetic opioid analgesic that inhibits reuptake of norepinephrine and serotonin while also acting as a weak mu-opioid receptor agonist to provide pain relief.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
placebo and tramadol TARGET placebo and tramadol University of Southern Denmark marketed Opioid analgesic with monoamine reuptake inhibition Mu-opioid receptor; norepinephrine transporter; serotonin transporter
Tramadol HCl/acetaminophen Extended Release Tramadol HCl/acetaminophen Extended Release Janssen Korea, Ltd., Korea marketed Opioid analgesic combination with NSAID alternative Mu-opioid receptor; norepinephrine transporter; serotonin transporter
Tramadol hydrochloride/ Acetaminophen Tramadol hydrochloride/ Acetaminophen Janssen Korea, Ltd., Korea marketed Opioid analgesic combination Mu-opioid receptor; norepinephrine transporter; serotonin transporter
Tramadol hydrochloride/Acetaminophen Tab. Tramadol hydrochloride/Acetaminophen Tab. Daewon Pharmaceutical Co., Ltd. phase 3 Opioid analgesic combination Mu-opioid receptor; norepinephrine transporter; serotonin transporter
Tramadol IV (Tradonal® IV) Tramadol IV (Tradonal® IV) University Hospital, Ghent marketed Opioid analgesic with monoamine reuptake inhibition Mu opioid receptor; norepinephrine transporter; serotonin transporter
Tramadol HCl Tramadol HCl Labopharm Inc. marketed Synthetic opioid analgesic with monoamine reuptake inhibition Mu opioid receptor; norepinephrine transporter; serotonin transporter
Tramadol 5% Tramadol 5% Al-Azhar University phase 3 Opioid analgesic with monoamine reuptake inhibition Mu opioid receptor; norepinephrine and serotonin transporters

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Opioid analgesic with monoamine reuptake inhibition class)

  1. Al-Azhar University · 1 drug in this class
  2. Pfizer · 1 drug in this class
  3. University Hospital, Ghent · 1 drug in this class
  4. University of Southern Denmark · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). placebo and tramadol — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-and-tramadol. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: